BioHealth News Archive
How Much Does Pharmaceutical Innovation Cost? A Look At 100 Companies – Forbes
No factor defines success and failure for a drug company more than this: Companies that invent more, better drugs at a lower cost do…
Read MoreEntrepreneurs Eye Technology To Cut Hospital Readmissions – iHealthBeat
Some hospitals are turning to technology entrepreneurs to reduce readmission rates and avoid penalties imposed under the Affordable Care Act, the Wall Street Journal…
Read MoreHow MyFitnessPal Became The Strongest Digital-Health Startup—Without Silicon Valley’s Help – ReadWrite
Kleiner Perkins, the investor behind Google and Amazon, and Accel Partners, best known for its investment in Facebook, are putting $18 million into MyFitnessPal,…
Read MoreHow Self-Expiring Medicine Packaging Could Change The World | Co.Design: business + innovation + design
For most of us, the blister packs our medicines come in are just temporary barriers to be scratched open with our fingernails or popped…
Read MoreNew dean at UMD business school – baltimoresun.com
The University of Maryland announced Monday that long-time finance professor Alexander J. Triantis has been appointed dean of the Robert H. Smith School of…
Read MoreFormal partnership may mean more SBIR/STTR funding – Bridging 96
Money may not make the world go round, but it does keep companies innovating. The Small Business & Technology Development Center has made formal…
Read MoreIncreasing the Impact of Federally-Funded R&D
by Joseph P. Allen and Diane Palmintera The Final ReportOn May 20, 2013, the White House Lab-To-Market Inter-Agency Summit was held in Washington, D.C. The…
Read MoreNHLBI Funding Opportunity Announcements – August 9, 2013
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:NIH Guide Notice: NOT-OD-13-095):…
Read MoreGlaxoSmithKline bases new VC fund at One Broadway in Kendall – Boston Business Journal
GlaxoSmithKline's new $50 million venture capital fund will be based out of the One Broadway building in Cambridge's Kendall Square, inside an office of…
Read MoreGSK launches $50M fund to invest in pioneering bioelectronics technology – MedCity News
About one year ago GlaxoSmithKline (NYSE: GSK) set up a division to study the electrical impulses along the peripheral nervous system and develop technologies…
Read MoreLife Sciences Discovery Fund 2013-2014 Granting Programs Now Open
Proof of Concept grants are intended to enhance the commercial viability of health-related technologies or concepts developed by non-profit organizations or enhance the competitiveness…
Read MorePharmAthene’s merger gives Annapolis biotech link to Pfizer – Baltimore Business Journal
When PharmAthene Inc. merges with Seattle-based Theraclone Sciences Inc., it will become part of a company that has the kind of deal with Big…
Read MoreNHLBI Job Opportunities: Business Development Specialist, Office of Translational Alliances and Coordination
The Office of Translational Alliances and Coordination (OTAC) in the Division of Extramural Research Activities (DERA), NHLBI is seeking outstanding candidates for the Business…
Read MoreCounty lands major State funding to support 9,700 new jobs
Leggett Joins O’Malley/Brown Administration in Announcing $630 Million Investment in County’s Transportation Network; Governor Also Announces Additional $400 Million for Construction of Purple Line…
Read MoreThe Return of the Biotech IPO | BIOtechNow
It isn’t just the volume of IPOs this summer that makes this window a victory for hibernating private biotechs and their VC backers, it’s…
Read More